Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

Université de Montréal

$747,951.00

The role of the tumour suppressor PAR-4/LKB1 in cell polarity and asymmetric cell division

FY 2010-11

Summary
Patients suffering from a disease called Peutz-Jeghers Syndrome (PJS) have a high risk (>90%) of developing tumors, mainly in the stomach and intestine. Tumors can also develop at various other sites, including lung, breast, pancreas, uterus, ovary, cervix and testis. Most PJS patients have mutations in a gene called LKB1, indicating that this is the gene that causes the disease and therefore that the normal function of LKB1 is to prevent the formation of tumors. However, how LKB1 performs this function is unknown. The goal of this research proposal is to understand how LKB1 functions in normal cells, to gain insights into its role during tumor formation. To do this, I am using a small worm called C. elegans. The advantage of using C. elegans as a model is that it is very easy to manipulate and its cells behave like human cells; therefore understanding a gene's function in this animal can help us to understand what it does in humans. I am using modern cell biology, molecular biology and genetic tools to identify and characterize novel genes that can function with LKB1 to control the division of normal cells. This work will contribute to define the precise role of LKB1 in cell division. Because all of the genes that we study are conserved in humans, the discoveries that we make will help to understand how these genes function in human cells. As mutations in LKB1 are associated with a high risk of developing cancer, this work will also allow a better understanding of the molecular and cellular events that lead to the formation of tumors upon loss of LKB1 activity in PJS patients.
Program
Operating Grant
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
209916
Name
Labbe Jean-Claude
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Genetics
Projecttitle
The role of the tumour suppressor PAR-4/LKB1 in cell polarity and asymmetric cell division
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$747,951
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Asymmetric Cell Division; C. Elegans Embryogenesis; Cancer; Cell Biology; Cell Fate Specification; Cell Polarization; Dna Replication; Genetic Analysis; Live Imaging; Lkb1 Signaling
Abstract
Patients suffering from a disease called Peutz-Jeghers Syndrome (PJS) have a high risk (>90%) of developing tumors, mainly in the stomach and intestine. Tumors can also develop at various other sites, including lung, breast, pancreas, uterus, ovary, cervix and testis. Most PJS patients have mutations in a gene called LKB1, indicating that this is the gene that causes the disease and therefore that the normal function of LKB1 is to prevent the formation of tumors. However, how LKB1 performs this function is unknown. The goal of this research proposal is to understand how LKB1 functions in normal cells, to gain insights into its role during tumor formation. To do this, I am using a small worm called C. elegans. The advantage of using C. elegans as a model is that it is very easy to manipulate and its cells behave like human cells; therefore understanding a gene's function in this animal can help us to understand what it does in humans. I am using modern cell biology, molecular biology and genetic tools to identify and characterize novel genes that can function with LKB1 to control the division of normal cells. This work will contribute to define the precise role of LKB1 in cell division. Because all of the genes that we study are conserved in humans, the discoveries that we make will help to understand how these genes function in human cells. As mutations in LKB1 are associated with a high risk of developing cancer, this work will also allow a better understanding of the molecular and cellular events that lead to the formation of tumors upon loss of LKB1 activity in PJS patients.
Competitiondate
201009
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Labbe, Jean-Claude
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $747,951~ $0~
Université de Montréal - $747,951 Grant (2010-11) | Canada Spends